ULTRASOUND GASTROSTOMY IS HERE.

the first FDA-cleared, ultrasound-based solution for bedside feeding tube placement

Shown to Significantly Reduce Per-Patient Hospital Cost and ICU Length of Stay

Houghton et al. 2024; Marshall et al. 2022;

The PUMA-G System

Benefits

Proven Reduction in Hospital Costs

Compared to the total cost of PEG procedures, the PUMA-G System delivers a significant reduction in hospital costs, substantial savings from shorter ICU and hospital lengths of stay, and revenue enhancement through optimization of suite productivity. (See Marshall, 2022 and Houghton, 2024 Studies, Below)

Performance

The FDA-cleared PUMA-G System has been successfully and safely used for bedside gastrostomy in several different settings where ultrasound is available - in many types of ICUs, as well as step-down units, ‘floor’ units, IR suites, and Long-Term Acute Care hospitals, by physicians and APPs.

Safety

The PUMA-G System can reduce risks from PEG blind sticks (organ damage); endoscope reprocessing (infections); or fluoroscopy (cancer) by enabling ultrasound visualization of tissue from stomach wall to surface.

Speed

Scheduling logjams for an operating suite can delay patient care and increase costs. Gastrostomy procedures done at the bedside leverage the skills of physicians at the point of care and results in more efficient patient care.

 

Implementing a Bedside Percutaneous Tracheostomy and Ultrasound Gastrostomy Team Reduces Length of Stay and Hospital Costs Across Multiple Critical Care Units in a 1500 Bed Tertiary Care Center

Landmark study published in 2024 demonstrated $34,778 reduction in per-patient hospital costs, driven by 10-day ICU Length of Stay Reduction


Length of Stay and Hospital Cost Reductions After Implementing Bedside Percutaneous Ultrasound Gastrostomy (PUG) in a Critical Care Unit

Groundbreaking study was published in May 2022 assessing efficiency advantages of PUG procedures compared to usual care (i.e. PEG or PRG). Results show 5-day ICULOS reduction, 8-day hospital LOS reduction, and $26,621 reduction in total hospital costs per patient. To access the full paper, click the link below.


COVID Pandemic: Tracheostomy + Percutaneous Ultrasound Gastrostomies (a.k.a. “TPUG”)

A study was conducted during in October 2020 to assess safety and efficacy of a tandem procedure combining Tracheostomy and Percutaneous Ultrasound Gastrostomy (TPUG) in COVID patients. To access the study abstract, click the link below.


PUG vs. PRG Retrospective Study

A 25-patient study out of Columbia University published in May 2021 in the Journal of Intensive Care Medicine compares PUG with PRG. Results demonstrate that PUG (1) is a safe bedside procedure; (2) can be performed by ultrasound trained physicians; and (3) reduces transport and care delays in COVID-19 patients. To access the full paper, click the link below.


 

QUOTES FROM PHYSICIAN USERS:

 

"This is simply the way of the future.”

- Critical Care Intensivist, for-profit hospital system


“The procedure was incredibly easy and efficient...

I truly believe PUMA-G will be available in most modern ICUs soon.”

- Interventional Pulmonologist, academic medical hospital


I want my entire team to be Percutaneous Ultrasound Gastrostomy (PUG) experts.”

- General Surgeon, community hospital


PUMA-G System Components:

puma-explained-resize.jpg
IBC-Balloon-explained.jpg
 
 
 
 

Discover More